News

FDA Chief Says He Wants Gene Therapy Head Prasad to Return
US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head ...
What to Expect from Sarepta Therapeutics's Earnings
Analysts expect Sarepta Therapeutics to report an earnings per share (EPS) of $1.01. The announcement from Sarepta ...
BioSpace5h
July Layoffs Skyrocket 487% YOY With Merck Cuts
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...
The New Republic30mOpinion
Laura Loomer Is Getting a Taste of Her Own Medicine
As Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
The New Republic on MSN20mOpinion
Elon Musk’s Worst Nightmare About DOGE Is Starting to Come True
The National Weather Service has received permission to hire hundreds of employees, CNN reported Tuesday. That includes 450 ...
The Bulwark20h
MAGA Diehards Say Loomer is on Big Pharma’s Payroll
After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...
BioSpace7h
Report of Patient Deaths Sends Agios Shares Seesawing
While the deaths occurred in patients who had been treated with Agios’ anemia treatment Pyrukynd, the biotech insisted in an ...
Investing.com Australia21h
FDA commissioner seeks to bring back former gene therapy head
Investing.com -- US Food and Drug Administration Commissioner Marty Makary is attempting to convince Vinay Prasad, who recently left his position as head of gene therapy and vaccines, to return to the ...